NASDAQ: HSDT
Solana Co Stock Forecast, Predictions & Price Target

Analyst price target for HSDT

Based on 1 analyst offering 12 month price targets for Solana Co

Min Forecast
$4.00+80.18%
Avg Forecast
$4.00+80.18%
Max Forecast
$4.00+80.18%

Should I buy or sell HSDT stock?

Based on 1 analyst offering ratings for Solana Co.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HSDT's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates HSDT as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their HSDT stock forecasts and price targets.

HSDT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-06

1 of 1

Forecast return on equity

Is HSDT forecast to generate an efficient return?

Company
-7.09%
Industry
18.88%
Market
157.46%
HSDT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HSDT forecast to generate an efficient return on assets?

Company
-7.02%
Industry
12.54%
HSDT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HSDT earnings per share forecast

What is HSDT's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.70
Avg 2 year Forecast
-$0.26
Avg 3 year Forecast
-$0.39

HSDT revenue forecast

What is HSDT's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$13.4M+122.92%
Avg 2 year Forecast
$13.4M+122.92%
Avg 3 year Forecast
$17.3M+188.18%
HSDT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HSDT revenue growth forecast

How is HSDT forecast to perform vs Medical Devices companies and vs the US market?

Company
56.05%
Industry
8.9%
Market
16.77%
HSDT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HSDT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HSDT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
HSDT$2.22$4.00+80.18%Strong Buy
NNOX$1.73$5.00+189.02%Strong Buy
RPID$2.63N/AN/A
RCEL$4.11$7.83+90.58%Buy
TMCI$2.01$4.33+115.57%Buy

Solana Co Stock Forecast FAQ

Is Solana Co Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: HSDT) stock is to Strong Buy HSDT stock.

Out of 1 analyst, 1 (100%) are recommending HSDT as a Strong Buy, 0 (0%) are recommending HSDT as a Buy, 0 (0%) are recommending HSDT as a Hold, 0 (0%) are recommending HSDT as a Sell, and 0 (0%) are recommending HSDT as a Strong Sell.

If you're new to stock investing, here's how to buy Solana Co stock.

What is HSDT's earnings growth forecast for 2026-2028?

(NASDAQ: HSDT) Solana Co's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 31.24%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 68.19%.

Solana Co's earnings in 2026 is -$40,890,000.On average, 4 Wall Street analysts forecast HSDT's earnings for 2026 to be -$38,732,962, with the lowest HSDT earnings forecast at -$47,461,362, and the highest HSDT earnings forecast at -$28,892,875. On average, 4 Wall Street analysts forecast HSDT's earnings for 2027 to be -$14,033,682, with the lowest HSDT earnings forecast at -$24,809,348, and the highest HSDT earnings forecast at -$2,311,430.

In 2028, HSDT is forecast to generate -$21,331,197 in earnings, with the lowest earnings forecast at -$20,494,679 and the highest earnings forecast at -$21,958,585.

What is HSDT's revenue growth forecast for 2026-2028?

(NASDAQ: HSDT) Solana Co's forecast annual revenue growth rate of 56.05% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.9%, and it is also forecast to beat the US market's average forecast revenue growth rate of 16.77%.

Solana Co's revenue in 2026 is $6,017,000.On average, 4 Wall Street analysts forecast HSDT's revenue for 2026 to be $738,171,672, with the lowest HSDT revenue forecast at $609,447,036, and the highest HSDT revenue forecast at $866,786,240. On average, 4 Wall Street analysts forecast HSDT's revenue for 2027 to be $738,171,672, with the lowest HSDT revenue forecast at $609,447,036, and the highest HSDT revenue forecast at $866,786,240.

In 2028, HSDT is forecast to generate $954,290,375 in revenue, with the lowest revenue forecast at $916,867,223 and the highest revenue forecast at $982,357,739.

What is HSDT's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: HSDT) forecast ROA is -7.02%, which is lower than the forecast US Medical Devices industry average of 12.54%.

What is HSDT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year HSDT price target, the average HSDT price target is $4.00, with the highest HSDT stock price forecast at $4.00 and the lowest HSDT stock price forecast at $4.00.

The Wall Street analyst predicted that Solana Co's share price could reach $4.00 by Apr 6, 2027. The average Solana Co stock price prediction forecasts a potential upside of 80.18% from the current HSDT share price of $2.22.

What is HSDT's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: HSDT) Solana Co's current Earnings Per Share (EPS) is -$1.85. On average, analysts forecast that HSDT's EPS will be -$0.70 for 2026, with the lowest EPS forecast at -$0.86, and the highest EPS forecast at -$0.53. On average, analysts forecast that HSDT's EPS will be -$0.26 for 2027, with the lowest EPS forecast at -$0.45, and the highest EPS forecast at -$0.04. In 2028, HSDT's EPS is forecast to hit -$0.39 (min: -$0.37, max: -$0.40).

What is HSDT's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: HSDT) forecast ROE is -7.09%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.